properties by combined collagen I compression and stromal cell culture

pharmacodane

Development of a bioreactor-system for pre-endothelialized cardiac patch generation with enhanced viscoelastic properties by combined collagen I compression and stromal cell culture

  • Treatment of terminal heart failure still poses a significant clinical problem. Cardiac tissue engineering could offer autologous solutions for the replacement of non-functional myocardial tissue. So far, soft matrix construction and missing large scale prevascularization prevented the application of sizeable cardiac repair patches. We developed a novel bioreactor system for semi-automatic compression of a collagen I hydrogel applying 16 times higher pressure than in previous studies.
  • Resistance towards compression stress was investigated for multiple cardiac-related cell types. For scaffold prevascuarization, a tubular cavity was imprinted during the compaction process. Primary cardiac-derived endothelial cells (EC) were isolated from human left atrial appendages (HLAA) and characterized by FACS and immunocytology. EC were then seeded into the preformed channel with dermal fibroblasts as interstitial cell component of the fully cellularized patch.
  • After eight days of constant perfusion culture within the same bioreactor, scaffold dynamic modulus and cell viability were analyzed. Endothelial proliferation and vessel maturation were examined by immunohistochemistry and transmission electron microscopy. Our design allowed for scaffold production and dynamic culture in a one-stop-shop model.
  • Enhanced compression and cell-mediated matrix remodeling induced a significant increase in scaffold stiffness while ensuring excellent cell survival. For the first time, we could isolate HLAA-derived EC with proliferative potential.
  • Endothelial cells within the central channel proliferated during flow culture, continuously expressing endothelial markers (CD31) and displaying basal membrane synthesis (collagen IV, ultrastructural analysis). After seven days of culture, a complete endothelial monolayer could be observed. Covering cells aligned themselves in flow direction and developed mature cell-cell-contacts.
pharmacodane
pharmacodane

IGF-1, human

RC216-12 1mg
EUR 451.5

IGF-1 Protein

abx060289-100ug 100 ug
EUR 493.2

IGF-1 Antibody

E19-6096 100μg/100μl
EUR 225
Description: Available in various conjugation types.

IGF-1 Antibody

E90303 100ul
EUR 255
Description: Available in various conjugation types.

IGF-1 Antibody

R30443 100 ug
EUR 356.15
Description: Insulin-like growth factor 1, also known as somatomedin C or mechano growth factor is a protein that in humans is encoded by the IGF1 gene. IGF-1 is a hormone similar in molecular structure to insulin. It plays an important role in childhood growth and continues to have anabolic effects in adults. A synthetic analog of the protein, mecasermin, is used for the treatment of growth failure. IGF-1 consists of 70 amino acids in a single chain with three intramolecular disulfide bridges.

IGF- 1 Plasmid

PVT7112 2 ug
EUR 319.2

IGF- 1 Antibody

ABD6096 100 ug
EUR 525.6

RM-1 Cell Line

CL-0198 1×10⁶ cells/vial
EUR 420
Description: Mus musculus, Mouse

rHu IGF-1 (cGMP)

AK9901-0000 1mg Ask for price

IGF-1 ELISA Kit

DEIA1901 96T
EUR 908.4
Description: The IGF-1 ELISA is an enzyme immunoassay for the quantitative in vitro diagnostic measurement of Insulin-like Growth Factor 1 (IGF-1) in serum.

Human IGF-1 LR3

SP-89927-100 100 ug
EUR 270

IGF-1 ELISA Kit

80572 96
EUR 490

Human IGF-1 ELISA

TBS3251 1x96-well plate
EUR 450
Description: Cell culture Supernate, Plasma/Serum IGF-1

IGF-1(M23) Antibody

BNCH0220-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(M23), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNCH0220-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(M23), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNC700220-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(M23), CF770 conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNC700220-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(M23), CF770 conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNC800220-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(M23), CF680 conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNC800220-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(M23), CF680 conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNC810220-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(M23), CF680R conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNC810220-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(M23), CF680R conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNC550220-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(M23), CF555 conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNC550220-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(M23), CF555 conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNC430220-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(M23), CF543 conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNC430220-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(M23), CF543 conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNC610220-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(M23), CF660R conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNC610220-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(M23), CF660R conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNC050220-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(M23), CF405M conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNC050220-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(M23), CF405M conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNCA0220-250 250uL
EUR 459.6
Description: Primary antibody against IGF-1(M23), APC conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNCAP0220-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(M23), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNCAP0220-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(M23), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNCP0220-250 250uL
EUR 459.6
Description: Primary antibody against IGF-1(M23), PerCP conjugate, Concentration: 0.1mg/mL

IGF-1(M23) Antibody

BNCR0220-250 250uL
EUR 459.6
Description: Primary antibody against IGF-1(M23), RPE conjugate, Concentration: 0.1mg/mL

Mouse IGF-1 Antibody

33079-05111 150 ug
EUR 215

Recombinant Rat IGF-1

REGFP-0901 10ug Ask for price

IGF-1 Blocking Peptide

DF6096-BP 1mg
EUR 234

Recombinant Human IGF-1

HEGFP-0901 100ug Ask for price

IGF-1, human recombinant

P1016-.02 20 µg
EUR 309.6
Description: Insulin-like growth factor I (IGF-1) is a polypeptide endocrine hormone structurally similar to insulin and is mainly produced in the liver when stimulated by growth hormone. IGF-1 is a growth factor that stimulates the proliferation of various cell types including muscle, bone, and cartilage tissue

IGF-1, human recombinant

P1016-.1 100 µg
EUR 598
Description: IGF-1, endocrine hormone, expressed in E.Coli, cross-species reactivity.

Recombinant Murine IGF-1

MEGFP-0614 10ug Ask for price

RM 06

T26101-10mg 10mg Ask for price
Description: RM 06

RM 06

T26101-1g 1g Ask for price
Description: RM 06

RM 06

T26101-1mg 1mg Ask for price
Description: RM 06

RM 06

T26101-50mg 50mg Ask for price
Description: RM 06

RM 06

T26101-5mg 5mg Ask for price
Description: RM 06

RM 49

T26102-10mg 10mg Ask for price
Description: RM 49

RM 49

T26102-1g 1g Ask for price
Description: RM 49

RM 49

T26102-1mg 1mg Ask for price
Description: RM 49

RM 49

T26102-50mg 50mg Ask for price
Description: RM 49

RM 49

T26102-5mg 5mg Ask for price
Description: RM 49

RM-133

T34335-10mg 10mg Ask for price
Description: RM-133

RM-133

T34335-1g 1g Ask for price
Description: RM-133

RM-133

T34335-1mg 1mg Ask for price
Description: RM-133

RM-133

T34335-50mg 50mg Ask for price
Description: RM-133

RM-133

T34335-5mg 5mg Ask for price
Description: RM-133

RM-018

T40269-10mg 10mg Ask for price
Description: RM-018

RM-018

T40269-1g 1g Ask for price
Description: RM-018

RM-018

T40269-1mg 1mg Ask for price
Description: RM-018

RM-018

T40269-50mg 50mg Ask for price
Description: RM-018

RM-018

T40269-5mg 5mg Ask for price
Description: RM-018

IGF-1(IGF1/1020) Antibody

BNCH1020-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(IGF1/1020), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNCH1020-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(IGF1/1020), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNCAP1020-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(IGF1/1020), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNCAP1020-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(IGF1/1020), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNC701020-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(IGF1/1020), CF770 conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNC701020-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(IGF1/1020), CF770 conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNC811020-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(IGF1/1020), CF680R conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNC811020-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(IGF1/1020), CF680R conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNC801020-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(IGF1/1020), CF680 conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNC801020-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(IGF1/1020), CF680 conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNC551020-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(IGF1/1020), CF555 conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNC551020-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(IGF1/1020), CF555 conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNC431020-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(IGF1/1020), CF543 conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNC431020-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(IGF1/1020), CF543 conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNC611020-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(IGF1/1020), CF660R conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNC611020-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(IGF1/1020), CF660R conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNC051020-100 100uL
EUR 238.8
Description: Primary antibody against IGF-1(IGF1/1020), CF405M conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNC051020-500 500uL
EUR 652.8
Description: Primary antibody against IGF-1(IGF1/1020), CF405M conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNCA1020-250 250uL
EUR 459.6
Description: Primary antibody against IGF-1(IGF1/1020), APC conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNCP1020-250 250uL
EUR 459.6
Description: Primary antibody against IGF-1(IGF1/1020), PerCP conjugate, Concentration: 0.1mg/mL

IGF-1(IGF1/1020) Antibody

BNCR1020-250 250uL
EUR 459.6
Description: Primary antibody against IGF-1(IGF1/1020), RPE conjugate, Concentration: 0.1mg/mL

IGF-I (1-3)

4026104.025 250 mg
EUR 112.35

IGF-I (1-3)

4026104.1 1 g
EUR 337.05

IGF-I (1-3)

5-01367 4 x 5mg Ask for price

IGF-I (1-3)

H-2468.0250 250.0mg
EUR 211.2
Description: Sum Formula: C12H19N3O6; CAS# [32302-76-4]

IGF-I (1-3)

H-2468.1000 1.0g
EUR 559.2
Description: Sum Formula: C12H19N3O6; CAS# [32302-76-4]

IGF-1(M23), 1mg/mL

BNUM0220-50 50uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

IGF-1(M23), 0.2mg/mL

BNUB0220-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

IGF-1(M23), 0.2mg/mL

BNUB0220-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Rat IGF-1 ELISA kit

LF-EK50545 1×96T
EUR 777.6

Rat IGF-1 ELISA Kit

GWB-ZZD062 1x96 well plate Ask for price

Rat IGF-1 ELISA Kit

80573 96
EUR 490

IGF-1, DES1-3, human

RC216-12B 100ug
EUR 203.56

IGF-1 ELISA KIT|Human

EF000135 96 Tests
EUR 826.8

Human IGF-1 ELISA Kit

E28L0569 96T
EUR 666.67

Human IGF-1 ELISA KIT

E42EH-82 96T/48T Ask for price

Mouse IGF-1 ELISA kit

LF-EK50549 1×96T
EUR 777.6

Mouse IGF-1 ELISA Kit

GWB-SKR077 96 Tests Ask for price

Human IGF-1 ELISA Kit

GWB-SKR125 96 Tests Ask for price

Mouse IGF-1 ELISA Kit

GWB-ZZD063 1x96 well plate Ask for price

IGF-1 (human) ELISA Kit

K4775-100 100 assays
EUR 970.8
Description: Sensitive, Colorimetric Assay

Mouse IGF-1 ELISA Kit

80574 96
EUR 490

IGF-1R

GWB-A96843 0.01 mg Ask for price

IGF-1 (Murine) ELISA Kit

EKA51893-5x96T 5x96T Ask for price

IGF-1 (Murine) ELISA Kit

EKA51893-96T 96T
EUR 446.9

IGF-1, N15 labeled, human

RC216-12N 5ug
EUR 125.26

Antibody for Human IGF-1

SPC-699D-A565 0.1mg
EUR 480
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 565.

Antibody for Human IGF-1

SPC-699D-A633 0.1mg
EUR 480
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 633.

Antibody for Human IGF-1

SPC-699D-A655 0.1mg
EUR 480
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 655.

Antibody for Human IGF-1

SPC-699D-A680 0.1mg
EUR 480
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 680.

Antibody for Human IGF-1

SPC-699D-A700 0.1mg
EUR 480
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 700.

Antibody for Human IGF-1

SPC-699D-APCCY7 0.1mg
EUR 565.2
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to APC/Cy7.

Antibody for Human IGF-1

SPC-699D-DY350 0.1mg
EUR 496.8
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 350.

Antibody for Human IGF-1

SPC-699D-DY405 0.1mg
EUR 483.6
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 405.

Antibody for Human IGF-1

SPC-699D-DY488 0.1mg
EUR 471.6
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 488.

Antibody for Human IGF-1

SPC-699D-DY594 0.1mg
EUR 474
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 594.

Antibody for Human IGF-1

SPC-699D-DY633 0.1mg
EUR 468
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 633.

Antibody for Human IGF-1

SPC-699D-P594 0.1mg
EUR 488.4
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to PE/ATTO 594.

Antibody for Human IGF-1

SPC-699D-STR 0.1mg
EUR 477.6
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Streptavidin.

Anti-Rat IGF-1 Antibody

5121-100 each
EUR 379.2

Anti-Rat IGF-1 Antibody

5121-30T each
EUR 175.2

Human IGF-1 GENLISA ELISA

KBH0103 1 x 96 wells
EUR 286

R³ IGF-1, human recombinant

4216-100 each
EUR 196.8

R³ IGF-1, human recombinant

4216-1G each
EUR 48018

R³ IGF-1, human recombinant

4216-1MG each
EUR 385.2

R³ IGF-1, human recombinant

4216-20MG each
EUR 2461.2

R³ IGF-1, human recombinant

4216-50MG each
EUR 4164

R³ IGF-1, human recombinant

4216-5MG each
EUR 1011.6

Anti-Human IGF-1 Antibody

102-P28 100 µg
EUR 245.7
Description: Insulin-like growth factor (IGF)-I (also known as somatomedin C and somatomedin A) and IGF-II (multiplication stimulating activity or MSA) belong to the family of insulin-like growth factors that are structurally homologous to proinsulin. Mature IGF-I and IGF-II share approximately 70% sequence identity. Both IGF-I and IGF-II are expressed in many tissues and cell types and may have autocrine, paracrine and endocrine functions. Mature IGF-I and IGF-II are highly conserved between the human, bovine and porcine proteins (100% identity), and exhibit cross-species activity.

Anti-Mouse IGF-1 Antibody

103-M240 100 µg
EUR 399
Description: Insulin-like growth factor (IGF)-I (also known as somatomedin C and somatomedin A) and IGF-II (multiplication stimulating activity or MSA) belong to the family of insulin-like growth factors that are structurally homologous to proinsulin. Mature IGF-I and IGF-II share approximately 70% sequence identity. Both IGF-I and IGF-II are expressed in many tissues and cell types and may have autocrine, paracrine and endocrine functions. Mature IGF-I and IGF-II are highly conserved between the human, bovine and porcine proteins (100% identity), and exhibit cross-species activity.

Anti-Mouse IGF-1 Antibody

103-P08G 100 µg
EUR 245.7
Description: Insulin-like growth factor (IGF)-I (also known as somatomedin C and somatomedin A) and IGF-II (multiplication stimulating activity or MSA) belong to the family of insulin-like growth factors that are structurally homologous to proinsulin. Mature IGF-I and IGF-II share approximately 70% sequence identity. Both IGF-I and IGF-II are expressed in many tissues and cell types and may have autocrine, paracrine and endocrine functions. Mature IGF-I and IGF-II are highly conserved between the human, bovine and porcine proteins (100% identity), and exhibit cross-species activity.

Plant cell cultures as food-aspects of sustainability and safety

Sustainability and safety aspects of plant cell cultures as food are presented. Applicability of dairy side streams as carbon source and use of natural growth enhancers in cultivation are shown. Biotechnologically produced cellular products are currently emerging to replace and add into the portfolio of agriculturally derived commodities.
Plant cell cultures used for food could supplement current food production. However, still many aspects need to be resolved before this new food concept can enter the market. Issues related to sustainability and safety for human consumption are relevant for both consumers and regulators. In this study, two plant cell cultures, deriving from arctic bramble (Rubus arcticus) and birch (Betula pendula), were cultivated using lactose-rich dairy side streams as alternative carbon sources to replace sucrose.
Biomasses were comparable to those of original plant cell culture media when up to 83% and 75% of the original sucrose was replaced by these side streams for arctic bramble and birch cell cultures, respectively. Furthermore, nutritional composition or sensory properties were not compromised. Synthetic plant growth regulators were replaced by natural components, such as coconut water and IAA for several subculture cycles.
Finally, it was shown that only trace amounts of free growth regulators are present in the cells at the harvesting point and assessment by freshwater crustaceans assay indicated that toxicity of the cells was not exceeding that of traditionally consumed bilberry fruit.

Stability of live attenuated classical swine fever cellculture vaccine virus in liquid form for developing an oral vaccine

Classical swine fever (CSF) is an important viral disease of pigs and controlled by vaccination. Unorganised backyard and wild pigs are difficult to vaccinate by needle vaccination. Here we formulated liquid vaccines using an Indian CSF cell culture vaccine virus and four stabilisers and evaluated their stability at 4 °C, 25 °C and 37 °C up to 24 h for use as oral vaccine.
The stabilisers were Lactalbumin hydrolysate-Trehalose, Lactalbumin hydrolysate-Trehalose-Gelatin, Lactalbumin hydrolysate-Lactose-Sucrose and Lactalbumin hydrolysate-Sucrose. The liquid vaccines, with or without stabilisers, were stable at 4 °C up to 24 h, whereas, a drop of one log10 titre was observed at 25 °C during the same period. At 37 °C, the virus titre diminished by only one log10 with the Lactalbumin hydrolysate-Trehalose (LT) stabiliser up to 24 h compared to two log10 losses in virus titre with other stabilisers and virus control.
We therefore conclude that for developing a CSF oral vaccine, the vaccine virus in liquid form can be used directly during the winter, whereas for developing the oral vaccine for summer, the LT stabiliser would provide maximum stability to the virus to withstand the warm temperature while maintaining adequate therapeutic titre for inducing a protective immune response.

rHu VEGF-121

AK8331-0002 2µg Ask for price

rHu VEGF-121

AK8331-0010 10µg Ask for price

rHu VEGF-121

AK8331-0100 100µg Ask for price

rHu VEGF-121

AK8331-1000 1mg Ask for price

rHu VEGF (cGMP)

AK9063-0000 1mg Ask for price

EG VEGF

cyt-338 5µg
EUR 60
Description: Recombinant Human Endocrine Gland Vascular Endothelial Growth Factor

EG VEGF protein

30R-AE013 20 ug
EUR 358
Description: Purified recombinant Human EG VEGF protein

EG VEGF antibody

20R-1607 100 ug
EUR 807.6
Description: Rabbit polyclonal EG VEGF antibody

EG VEGF antibody

70R-EG002 50 ug
EUR 312
Description: Affinity purified Goat polyclonal EG VEGF antibody

EG VEGF Rabbit mAb

E2R389402 100ul
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

OPPA00601-5UG - EG VEGF Protein

OPPA00601-5UG 5ug
EUR 70

Recombinant Human VEGF165 (rHu VEGF165)

70505 10ul
EUR 235
Description: Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using human umbilical vein endothelial cells(HUVEC) is between 1.0-8.0 ng/ml.

EG-VEGF

PR29003 5 ug
EUR 277.2

Recombinant Mouse EG VEGF Protein, Untagged, E.coli-1mg

QP11757-1mg 1mg
EUR 3308.4

Recombinant Mouse EG VEGF Protein, Untagged, E.coli-5ug

QP11757-5ug 5ug
EUR 186

Recombinant Mouse EG VEGF Protein, Untagged, E.coli-20ug

QP11757-20ug 20ug
EUR 241.2

EG-VEGF Antibody

3489-100 each
EUR 405.6

EG-VEGF Antibody

3489R-100 each
EUR 379.2

EG-VEGF Antibody

3489R-30T each
EUR 175.2

Rat Endocrine gland vascular endothelial growth factor, EG- VEGF

ELA-E0024r 96 Tests
EUR 1063.2

EG-VEGF Recombinant Protein

40-629 5 ug
EUR 311.1
Description: EG-VEGF is a secreted angiogenetic mitogen growth factor expressed in the steroidogenic glands, ovary, testis, adrenal gland, and placenta. EG-VEGF induces proliferation, migration, and fenestration (formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. The human EG-VEGF gene codes for a 105 amino acid polypeptide containing an N-terminal signal sequence of 19 amino acids. Recombinant Human EG-VEGF is a 9.6 kDa protein consisting of 86 amino acid residues, including ten cysteine residues that potentially form five pairs of intra-molecular disulfide bonds.

EG-VEGF Recombinant Protein

40-702 5 ug
EUR 311.1
Description: EG-VEGF is a secreted angiogenetic mitogen growth factor expressed in the steroidogenic glands, ovary, testis, adrenal gland, and placenta. EG-VEGF induces proliferation, migration, and fenestration (formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. The murine EG-VEGF gene codes for a 105 amino acid polypeptide containing an N-terminal signal sequence of 19 amino acids. Recombinant Murine EG-VEGF is a 9.6 kDa protein consisting of 86 amino acid residues, including ten cysteine residues that potentially form five pairs of intra-molecular disulfide bonds.

EG-VEGF, human recombinant

4571-10 each
EUR 183.6

EG-VEGF, human recombinant

4571-1000 each
EUR 3583.2

EG-VEGF, human recombinant

4571-50 each
EUR 483.6

Polyclonal EG-VEGF Antibody

APR00114G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EG-VEGF . This antibody is tested and proven to work in the following applications:

Polyclonal EG-VEGF Antibody

APG00002G 0.1ml
EUR 580.8
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human EG-VEGF . This antibody is tested and proven to work in the following applications:

EG-VEGF Blocking Peptide

20-abx064278
  • Ask for price
  • Ask for price
  • 1 mg
  • 5 mg

Recombinant Human EG-VEGF

HEGFP-0503 5ug Ask for price

Anti-EG-VEGF Antibody

HA500078 100ul
EUR 189
Description: The protein encoded by this gene induces proliferation, migration, and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. It has little or no effect on a variety of other endothelial and non-endothelial cell types. Its expression is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta), is induced by hypoxia, and often complementary to the expression of vascular endothelial growth factor (VEGF), suggesting that these molecules function in a coordinated manner.

Recombinant Murine EG-VEGF

MEGFP-0502 5ug Ask for price

VEGF-A(VEGF/1063) Antibody

BNCAP1063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNCAP1063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNCH1063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNCH1063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNC701063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF770 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNC701063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF770 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNC811063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF680R conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNC811063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF680R conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNC801063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF680 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNC801063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF680 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNC551063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF555 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNC551063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF555 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNC431063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF543 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNC431063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF543 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNC611063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF660R conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNC611063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF660R conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNC051063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF405M conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNC051063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF405M conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNCA1063-250 250uL
EUR 459.6
Description: Primary antibody against VEGF-A(VEGF/1063), APC conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNCP1063-250 250uL
EUR 459.6
Description: Primary antibody against VEGF-A(VEGF/1063), PerCP conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody

BNCR1063-250 250uL
EUR 459.6
Description: Primary antibody against VEGF-A(VEGF/1063), RPE conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063), 1mg/mL

BNUM1063-50 50uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), 0.2mg/mL

BNUB1063-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), 0.2mg/mL

BNUB1063-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF/ Rat VEGF ELISA Kit

ELA-E0143r 96 Tests
EUR 1063.2

Anti-Human EG-VEGF Antibody

102-P113G 100 µg
EUR 245.7
Description: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF), also called prokineticin 1 (PK1), is a member of the prokineticin family of secreted proteins that share a common structural motif containing ten conserved cysteine residues that form five pairs of disulfide bonds. Members of this family include the mammalian EG-VEGF/ PK1 and PK2, as well as the venom protein A (VPRA) from the venom of black mamba snake and the frog Bombina variegata, Bv8. Human EG-VEGF precursor is a 105 amino acid (aa) residue protein with a 19 aa signal peptide that is cleaved to yield a 86 aa mature protein. EG-VEGF is expressed in multiple tissues including the gastrointestinal (GI) tract and steroidogenic glands (testis, ovary, placenta and adrenal glands). EG-VEGF has been shown to potently stimulate the contraction of GI smooth muscle. In addition, EG-VEGF is a tissue-specific angiogenic factor that exhibits biological activities similar to that of VEGF on select cells. It induces the proliferation, migration, and fenestration in cultured endocrine gland-derived capillary endothelial cells. EG-VEGF binds to and activates two closely related G proteincoupled receptors, EG-VEGF/ PK1R1 and EG-VEGF/ PK2R2. Activation of the receptors leads to stimulation of phosphoinositide turnover and activation of p44/p42 MAP kinase signaling pathways.

Anti-Human EG-VEGF Antibody

101-M158 100 µg
EUR 399
Description: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF), also called prokineticin 1 (PK1), is a member of the prokineticin family of secreted proteins that share a common structural motif containing ten conserved cysteine residues that form five pairs of disulfide bonds. Members of this family include the mammalian EG-VEGF/ PK1 and PK2, as well as the venom protein A (VPRA) from the venom of black mamba snake and the frog Bombina variegata, Bv8. Human EG-VEGF precursor is a 105 amino acid (aa) residue protein with a 19 aa signal peptide that is cleaved to yield a 86 aa mature protein. EG-VEGF is expressed in multiple tissues including the gastrointestinal (GI) tract and steroidogenic glands (testis, ovary, placenta and adrenal glands). EG-VEGF has been shown to potently stimulate the contraction of GI smooth muscle. In addition, EG-VEGF is a tissue-specific angiogenic factor that exhibits biological activities similar to that of VEGF on select cells. It induces the proliferation, migration, and fenestration in cultured endocrine gland-derived capillary endothelial cells. EG-VEGF binds to and activates two closely related G proteincoupled receptors, EG-VEGF/ PK1R1 and EG-VEGF/ PK2R2. Activation of the receptors leads to stimulation of phosphoinositide turnover and activation of p44/p42 MAP kinase signaling pathways.

Anti-Human EG-VEGF Antibody

101-M633 100 µg
EUR 399
Description: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF), also called prokineticin 1 (PK1), is a member of the prokineticin family of secreted proteins that share a common structural motif containing ten conserved cysteine residues that form five pairs of disulfide bonds. Members of this family include the mammalian EG-VEGF/ PK1 and PK2, as well as the venom protein A (VPRA) from the venom of black mamba snake and the frog Bombina variegata, Bv8. Human EG-VEGF precursor is a 105 amino acid (aa) residue protein with a 19 aa signal peptide that is cleaved to yield a 86 aa mature protein. EG-VEGF is expressed in multiple tissues including the gastrointestinal (GI) tract and steroidogenic glands (testis, ovary, placenta and adrenal glands). EG-VEGF has been shown to potently stimulate the contraction of GI smooth muscle. In addition, EG-VEGF is a tissue-specific angiogenic factor that exhibits biological activities similar to that of VEGF on select cells. It induces the proliferation, migration, and fenestration in cultured endocrine gland-derived capillary endothelial cells. EG-VEGF binds to and activates two closely related G proteincoupled receptors, EG-VEGF/ PK1R1 and EG-VEGF/ PK2R2. Activation of the receptors leads to stimulation of phosphoinositide turnover and activation of p44/p42 MAP kinase signaling pathways.

Human EG-VEGF Recombinant Protein

100-150 20 µg
EUR 196.35
Description: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) induces proliferation, migration, and fenestration in capillary endothelial cells derived from endocrine glands. Its expression is induced by hypoxia and is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta). Its expression is often complementary to the expression of VEGF (MIM 192240), suggesting that these molecules function in a coordinated manner. EG-VEGF potently contracts gastrointestinal (gi) smooth muscle. Induces proliferation, migration and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. Has little or no effect on a variety of other endothelial and non-endothelial cell types.

Human EG-VEGF Recombinant Protein

100-150S 5 µg
EUR 92.4
Description: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) induces proliferation, migration, and fenestration in capillary endothelial cells derived from endocrine glands. Its expression is induced by hypoxia and is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta). Its expression is often complementary to the expression of VEGF (MIM 192240), suggesting that these molecules function in a coordinated manner. EG-VEGF potently contracts gastrointestinal (gi) smooth muscle. Induces proliferation, migration and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. Has little or no effect on a variety of other endothelial and non-endothelial cell types.

Rabbit anti-EG-VEGF Antibody

DL92084A-100ul 100 ul
EUR 299
Description: Prokineticin-1; Endocrine-gland-derived vascular endothelial growth factor; EG-VEGF; Mambakine

Rabbit anti-EG-VEGF Antibody

DL92084A-50ul 50 ul
EUR 209.3
Description: Prokineticin-1; Endocrine-gland-derived vascular endothelial growth factor; EG-VEGF; Mambakine

Porcine EG-VEGF ELISA Kit

EPE0137 96Tests
EUR 625.2

Rat EG-VEGF ELISA Kit

ERE0137 96Tests
EUR 625.2

Mouse EG-VEGF ELISA Kit

EME0137 96Tests
EUR 625.2

Monkey EG-VEGF ELISA Kit

EMKE0137 96Tests
EUR 625.2

Rabbit EG-VEGF ELISA Kit

ERTE0137 96Tests
EUR 625.2

Sheep EG-VEGF ELISA Kit

ESE0137 96Tests
EUR 625.2

EG-VEGF (Human) ELISA Kit

EKA51829-5x96T 5x96T Ask for price

EG-VEGF (Human) ELISA Kit

EKA51829-96T 96T
EUR 446.9

Human EG-VEGF ELISA Kit

EK5247 96 tests
EUR 599

Goat EG-VEGF ELISA Kit

EGTE0137 96Tests
EUR 625.2

Anserini EG-VEGF ELISA Kit

EAE0137 96Tests
EUR 625.2

Chicken EG-VEGF ELISA Kit

ECKE0137 96Tests
EUR 625.2

EG-VEGF ELISA KIT|Human

EF000094 96 Tests
EUR 826.8

Canine EG-VEGF ELISA Kit

ECE0137 96Tests
EUR 625.2

Bovine EG-VEGF ELISA Kit

EBE0137 96Tests
EUR 625.2

Human EG-VEGF ELISA Kit

EHE0137 96Tests
EUR 625.2

Prokineticin 1 (EG-VEGF) Antibody

20-abx007755
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 30 ul

Mouse EG-VEGF Recombinant Protein

M10-236 20 µg
EUR 196.35
Description: EG-VEGF is a secreted angiogenetic mitogen growth factor expressed in the steroidogenic glands, ovary, testis, adrenal and placenta.  EG-VEGF induces proliferation and migration fenestration (formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands.  The murine EG-VEGF gene codes for a 105 amino acid polypeptide containing an N-terminal signal sequence of 19 amino acids.  Recombinant murine EG-VEGF is a 9.6 kDa protein consisting of 86 amino acid residues and ten cysteine residues that potentially form five pairs of intra-molecular disulfide bonds.

Mouse EG-VEGF Recombinant Protein

M10-236S 5 µg
EUR 92.4
Description: EG-VEGF is a secreted angiogenetic mitogen growth factor expressed in the steroidogenic glands, ovary, testis, adrenal and placenta.  EG-VEGF induces proliferation and migration fenestration (formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands.  The murine EG-VEGF gene codes for a 105 amino acid polypeptide containing an N-terminal signal sequence of 19 amino acids.  Recombinant murine EG-VEGF is a 9.6 kDa protein consisting of 86 amino acid residues and ten cysteine residues that potentially form five pairs of intra-molecular disulfide bonds.

Human EG-VEGF ELISA kit

LF-EK50695 1×96T
EUR 777.6

Human EG-VEGF ELISA Kit

GWB-SKR013 96 Tests Ask for price

Human EG-VEGF ELISA Kit

GWB-ZZD183 1x96 well plate Ask for price

EG-VEGF Antibody / Prokineticin 1

R32153 100 ug
EUR 356.15
Description: Prokineticin-1 is also known as EG-VEGF. The International Radiation Hybrid Mapping Consortium mapped the PROK1 gene to chromosome 1. The protein encoded by this gene induces proliferation, migration, and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. It has little or no effect on a variety of other endothelial and non-endothelial cell types. Its expression is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta), is induced by hypoxia, and often complementary to the expression of vascular endothelial growth factor (VEGF), suggesting that these molecules function in a coordinated manner.

Eg-Vegf Antibody / Prokineticin-1

R32231 100 ug
EUR 356.15
Description: Prokineticin-1 is also known as EG-VEGF. The International Radiation Hybrid Mapping Consortium mapped the PROK1 gene to chromosome 1. The protein encoded by this gene induces proliferation, migration, and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. It has little or no effect on a variety of other endothelial and non-endothelial cell types. Its expression is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta), is induced by hypoxia, and often complementary to the expression of vascular endothelial growth factor (VEGF), suggesting that these molecules function in a coordinated manner.

Human EG-VEGF GENLISA ELISA

KB1036 1 x 96 wells
EUR 198

OPSD00006-5UG - Recombinant EG-VEGF

OPSD00006-5UG 5ug
EUR 108

Rabbit anti-EG-VEGF Antibody

YLD2727-100ul 100 ul
EUR 320
Description: Rabbit polyclonal antibody to EG-VEGF

Rabbit anti-EG-VEGF Antibody

YLD2727-50ul 50 ul
EUR 200
Description: Rabbit polyclonal antibody to EG-VEGF

Recombinant Human EG-VEGF (PROK1)

Z100145 20 µg
EUR 235
Description: This factor is identical to prokineticin-1 and is a member of the AVIT protein family. Expression of human EG-VEGF messenger RNA is restricted to the steroidogenic glands, ovary, testis, adrenal and placenta and is often complementary to the expression of VEGF. EG-VEGF has been identified as a mitogen specific for the endothelium of steroidogenic glands. EG-VEGF resembles VEGF in that it causes extensive angiogenesis and cyst formation when delivered in the ovary. EG-VEGF differs from VEGF in that it does not promote angiogenesis in the cornea or skeletal muscle. Two receptors have been characterized and are expressed in gastrointestinal organs, endocrine glands and other tissues. The G-protein-coupled receptors ZAQ and I5E both function as the EG-VEGF receptor.

Recombinant Human EG-VEGF (PROK1)

Z100149 1.0 mg
EUR 3900
Description: This factor is identical to prokineticin-1 and is a member of the AVIT protein family. Expression of human EG-VEGF messenger RNA is restricted to the steroidogenic glands, ovary, testis, adrenal and placenta and is often complementary to the expression of VEGF. EG-VEGF has been identified as a mitogen specific for the endothelium of steroidogenic glands. EG-VEGF resembles VEGF in that it causes extensive angiogenesis and cyst formation when delivered in the ovary. EG-VEGF differs from VEGF in that it does not promote angiogenesis in the cornea or skeletal muscle. Two receptors have been characterized and are expressed in gastrointestinal organs, endocrine glands and other tissues. The G-protein-coupled receptors ZAQ and I5E both function as the EG-VEGF receptor.

VEGF

E8ET1604-28 100ul
EUR 275
Description: Available in various conjugation types.

VEGF

GWB-400310 0.01 mg Ask for price

VEGF

cyt-241 2µg
EUR 60
Description: Recombinant Human Vascular Endothelial Growth Factor

VEGF

ant-125 0.5mg
EUR 275
Description: Mouse Anti Human Vascular Endothelial Growth Factor

VEGF

LF-PR009 10 ug
EUR 306
Description: VEGF protein

VEGF

MO15067 500 ug
EUR 1092

VEGF

PR15028 10 ug
EUR 553.2

VEGF Rabbit Polyclonal Antibody(VEGF)

RA20266-100ul 100 ul
EUR 298

VEGF Rabbit Polyclonal Antibody(VEGF)

RA20266-50ul 50 ul
EUR 198

VEGF 121

PR15029 5 ug
EUR 498

VEGF 162

PR15030 25 ug
EUR 553.2

VEGF 165

PR15031 50 ug
EUR 1477.2

VEGF 120

PR15033 5 ug
EUR 459.6

VEGF 164

PR15034 25 ug
EUR 1352.4

VEGF 164

PR15035 50 ug
EUR 1477.2

VEGF (121a.a.)

cyt-343 2µg
EUR 60
Description: Recombinant Human Vascular Endothelial Growth Factor (121)

VEGF-A/ Rat VEGF- A ELISA Kit

ELA-E1851r 96 Tests
EUR 1063.2

VEGF-B/ Rat VEGF- B ELISA Kit

ELA-E0144r 96 Tests
EUR 1063.2

VEGF-C/ Rat VEGF- C ELISA Kit

ELA-E0145r 96 Tests
EUR 1063.2

VEGF-D/ Rat VEGF- D ELISA Kit

ELA-E0146r 96 Tests
EUR 1063.2

VEGF-A(VEGF/1063), CF568 conjugate, 0.1mg/mL

BNC681063-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), CF568 conjugate, 0.1mg/mL

BNC681063-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), CF647 conjugate, 0.1mg/mL

BNC471063-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), CF647 conjugate, 0.1mg/mL

BNC471063-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), CF594 conjugate, 0.1mg/mL

BNC941063-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), CF594 conjugate, 0.1mg/mL

BNC941063-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), Biotin conjugate, 0.1mg/mL

BNCB1063-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), Biotin conjugate, 0.1mg/mL

BNCB1063-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), CF488A conjugate, 0.1mg/mL

BNC881063-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), CF488A conjugate, 0.1mg/mL

BNC881063-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), CF405S conjugate, 0.1mg/mL

BNC041063-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), CF405S conjugate, 0.1mg/mL

BNC041063-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), CF640R conjugate, 0.1mg/mL

BNC401063-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF-A(VEGF/1063), CF640R conjugate, 0.1mg/mL

BNC401063-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

VEGF D

cyt-045 2µg
EUR 60
Description: Recombinant Human Vascular Endothelial Growth Factor D

VEGF, CF

PR15028CF 10 ug
EUR 553.2

VEGF, HEK

cyt-225 2µg
EUR 60
Description: Recombinant Human Vascular Endothelial Growth Factor, HEK

VEGF, CHO

cyt-260 2µg
EUR 60
Description: Recombinant Human Vascular Endothelial Growth Factor, CHO

VEGF, His

cyt-496 5µg
EUR 60
Description: Recombinant Human Vascular Endothelial Growth Factor, His Tag

mEG VEGF

cyt-825 5µg
EUR 60
Description: Recombinant Mouse Endocrine Gland Vascular Endothelial Growth Factor

VEGF rat

JP27101 96
EUR 611

VEGF-C

JP27756 96
EUR 611

VEGF-B

RA26004 100 ul
EUR 646.8

VEGF-D

RA26005 100 ul
EUR 646.8

VEGF-C

PR27170 2 ug
EUR 229.2

VEGF-C

PR27170-B each
EUR 2519.1

VEGF-C

PR27170-M each
EUR 175.5

VEGF 121, CF

PR15029CF 5 ug
EUR 498

VEGF 162, CF

PR15030CF 25 ug
EUR 553.2

VEGF 165, CF

PR15031CF 50 ug
EUR 1477.2

VEGF 164, CF

PR15034CF 5 ug
EUR 459.6

VEGF 164, CF

PR15035CF 50 ug
EUR 1477.2

Goat(VEGF)

QY-E140039 96T
EUR 495.6

Guinea Pig EG-VEGF ELISA Kit

EGE0137 96Tests
EUR 625.2

Human EG-VEGF PicoKine ELISA Kit

EK0575 96 wells
EUR 547.2
Description: For quantitative detection of human EG-VEGF in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA).

Human EG-VEGF ELISA kit (4X96T)

LF-EK50696 4×96T
EUR 2641.2

Mouse EG-VEGF Recombinant Protein Lyophilized

IMSEGVEGFRLY5UG each
EUR 317
Description: Mouse EG-VEGF Recombinant Protein Lyophilized

Human EG-VEGF Recombinant Protein Lyophilized

IHUEGVEGFRLY5UG each
EUR 317
Description: Human EG-VEGF Recombinant Protein Lyophilized

EG-VEGF ELISA Kit (Human) (OKBB00283)

OKBB00283 96 Tests
EUR 652.8
Description: Description of target: EG-VEGF, Endocrine glandderived vascular endothelial growth factor, is a human protein encoded by by the PROKR1 gene. Its gene is mapped to chromosome 1. The 1.4-kb cDNA encodes a protein of 105 amino acids with a well defined signal sequence. The mature protein is predicted to have 86 amino acids. Northern blot analysis demonstrated expression in testis, ovary, adrenal gland, and placenta. EG-VEGF has played a vital role in inducing proliferation, migration, and fenestration in capillary endothelial cells derived from endocrine glands.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 7 pg/mL

VEGF-121-Fc

E13-m005-1 10μg
EUR 225
Description: N/A

VEGF-121-Fc

E13-m005-2 50μg
EUR 1125
Description: N/A

VEGF-165-Fc

E13-m006-1 10μg
EUR 225
Description: N/A

VEGF-165-Fc

E13-m006-2 50μg
EUR 1125
Description: N/A

VEGF, Plant

cyt-1213 2µg
EUR 60
Description: Recombinant Human Vascular Endothelial Growth Factor, Plant

VEGF, Yeast

cyt-577 2µg
EUR 60
Description: Recombinant Human Vascular Endothelial Growth Factor, Yeast

VEGF mouse

JP27102 96
EUR 611

VEGF human

JP27171 96
EUR 611

VEGF (121a.a.), HEK

cyt-116 2µg
EUR 60
Description: Recombinant Human Vascular Endothelial Growth Factor (121), HEK

VEGF (121a.a.), Sf9

cyt-200 2µg
EUR 60
Description: Recombinant Human Vascular Endothelial Growth Factor (121), Sf9

VEGF (121a.a.), His

cyt-619 2µg
EUR 60
Description: Recombinant Human Vascular Endothelial Growth Factor (121), His Tag

rHu MIF

AK8255-0005 5µg Ask for price

rHu MIF

AK8255-0025 25µg Ask for price

rHu MIF

AK8255-0100 100µg Ask for price

rHu MIF

AK8255-1000 1mg Ask for price

rHu EGF

AK8327-0100 100µg Ask for price

rHu EGF

AK8327-0500 500µg Ask for price

Skriv et svar

Din e-mailadresse vil ikke blive publiceret.